—
C+
C+ The full Closelook — membership. Open the C+ overview

Virbac SA (VIRP.PA) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Virbac SA

VIRP.PA in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Virbac makes health products for pets and farm animals, including vaccines, parasiticides, antibiotics, anti-inflammatories, dermatology treatments, diagnostics and pet food, sold to vets, farmers and pet owners across many regions. It is headquartered in Carros, France.
Where it sits in the stack
Virbac sits outside our AI build-out coverage; it belongs to the Healthcare sector of the wider universe, in the veterinary pharmaceuticals and animal-health sleeve rather than any Closelook index.
Who it is priced against
Closelook has not placed Virbac in a peer group; the comparison the market draws is with Zoetis, the larger listed animal-health company.
Why Closelook tracks it
Virbac holds no seat in any Closelook index, carries no Closelook score, and does not appear among the diary's quoted names or editions.
What the diary watches
The diary watches whether the recent pullback below its trend lines steadies, since Virbac's business turns on veterinary and farm demand rather than any AI-related driver.

Virbac SA (VIRP.PA) trades on the PA exchange in France.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for VIRP.PA, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Drug Manufacturers - General · 8 names with week and year-to-date

Peer group

Drug Manufacturers - General

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against VIRP.PA on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Virbac SA (VIRP.PA)?

Virbac SA trades as VIRP.PA on the PA exchange (France) in the Closelook research universe, as of the registry build of 2026-09-18.

Is VIRP.PA in a Closelook index?

Not currently — Virbac SA is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does VIRP.PA trade against its moving averages?

Downtrend stack: Trades -4.2% vs the 50-day and -9% vs the 200-day average, 18.9% below the 52-week high and +4.5% off the 52-week low; a death cross printed 54 sessions ago. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Virbac SA do?

Virbac makes health products for pets and farm animals, including vaccines, parasiticides, antibiotics, anti-inflammatories, dermatology treatments, diagnostics and pet food, sold to vets, farmers and pet owners across many regions. It is headquartered in Carros, France. Closelook has not placed Virbac in a peer group; the comparison the market draws is with Zoetis, the larger listed animal-health company.

Where does Virbac SA sit in the AI build-out?

Virbac sits outside our AI build-out coverage; it belongs to the Healthcare sector of the wider universe, in the veterinary pharmaceuticals and animal-health sleeve rather than any Closelook index. Virbac holds no seat in any Closelook index, carries no Closelook score, and does not appear among the diary's quoted names or editions.

What does this page show?

A live price chart with SMA overlays and drawing tools for VIRP.PA, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.